Loading your page…
Schizophrenia;Bipolar Disorder
Marketing Authorisation Holder: Ferrer Internacional S.A.
EMA Authorisation: 20/02/2013
INN: loxapine
AI Drug & Interaction Analysis
Free account required
Ask Osler about Adasuve: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.
